These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

120 related items for PubMed ID: 7089046

  • 1. Effects of carbamylation of plasma proteins and competitive displacers on drug binding in uremia.
    Calvo R, Carlos R, Erill S.
    Pharmacology; 1982; 24(4):248-52. PubMed ID: 7089046
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Abnormal serum protein binding of acidic drugs in diabetes mellitus.
    Ruiz-Cabello F, Erill S.
    Clin Pharmacol Ther; 1984 Nov; 36(5):691-5. PubMed ID: 6488690
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Correction of protein binding defect in uremic sera by charcoal treatment.
    Craig WA, Evenson MA, Sarver KP, Wagnild JP.
    J Lab Clin Med; 1976 Apr; 87(4):637-47. PubMed ID: 1270877
    [Abstract] [Full Text] [Related]

  • 6. Inability of accumulated metabolic byproducts of uremia to alter the extent of warfarin binding in charcoal treated plasma.
    Bachmann K, Conway P, Shapiro R.
    Res Commun Chem Pathol Pharmacol; 1978 Apr; 20(1):117-30. PubMed ID: 663394
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. In vitro inhibition of low density lipoprotein carbamylation by vitamins, as an ameliorating atherosclerotic risk in uremic patients.
    Ghaffari MA, Shanaki M.
    Scand J Clin Lab Invest; 2010 Apr; 70(2):122-7. PubMed ID: 20156036
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Isolation of peptides from uremic plasma that inhibit phenytoin binding to normal plasma proteins.
    Kinniburgh DW, Boyd ND.
    Clin Pharmacol Ther; 1981 Aug; 30(2):276-80. PubMed ID: 7249510
    [Abstract] [Full Text] [Related]

  • 17. Valproate plasma protein binding in the uremic condition.
    Brewster D, Muir NC.
    Clin Pharmacol Ther; 1980 Jan; 27(1):76-82. PubMed ID: 6985855
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. PON-1 carbamylation is enhanced in HDL of uremia patients.
    Chang CT, Lim YP, Lee CW, Liao HY, Chen FY, Chang CM, Tang FY, Yang CY, Chen CJ.
    J Food Drug Anal; 2019 Apr; 27(2):542-550. PubMed ID: 30987726
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.